In the last year, there’s been an upward trend in cloud adoption in India. In fact, NASSCOM finds that cloud spending in India is estimated to grow at 30% per annum to cross the US$7 billion mark by 2022.

At Google, in our conversations with customers, discussions have evolved beyond cost savings and efficiencies. While those are still very relevant reasons for adopting cloud technologies, Indian enterprises are looking to Google Cloud to help them drive digital transformation, identify new revenue generating business models, reach previously untapped consumer markets, and build customer loyalty through greater insight and personalization.

Here are some companies and their stories.

Tata Steel: Mining data and maximizing its power

Tata Steel is a great example of an established enterprise from a traditional industry that is modernizing and embracing cloud computing. With an ambition to be a leader in manufacturing in India and a digital-first organization by 2022, Tata Steel believes smart analytics is key to enhancing operational efficiency and gaining business advantage. 

To organize data from siloed systems across the organization and make it easily accessible to all employees, Tata Steel is using Cloud Search and plans to scale it to more than one million documents and 28 disparate enterprise content sources including enterprise resource planning (ERP) and SharePoint. In fact, Tata Steel is one of the first Indian enterprises to harness the power of Cloud Search to meet some of the most aggressive ingestion demands, with indexing durations reduced from weeks to seconds.

They are also leveraging Google Cloud Platform (GCP) services like Google Cloud Storage and BigQuery to build their data lake and enterprise data warehouse so they can take advantage of advanced analytics and machine learning. Managed services such as AI Platform further enable Tata Steel to manage end-to-end AI/ML workflows within the GCP console. This complements their existing on-premise reporting and analytics tools, and brings data management to the forefront of everything they do—from forecasting market demand to predictive equipment maintenance.

“Digital is not just a goal, it’s become a way of life. We are digitizing everything from the deployment of factory vehicles to improving material throughput to marketing and sales. As a result, we have petabytes of structured and unstructured data that is not only waiting to be mined, but that we can generate intelligence from to create opportunities across our multiple lines of business using GCP,” said Sarajit Jha, Chief Business Transformation & Digital Solutions at Tata Steel.

Helping L&T Financial Services reach customers in rural communities

In rural communities, quick access to financial services can make a tremendous difference to livelihoods. L&T Financial Services provides farm-equipment finance, micro loans and two-wheeler finance to consumers across rural India backed by a strong digital and analytics platform. Their digital-loan approval app, which runs on GCP, makes it significantly faster and easier for people to apply for financial assistance to purchase important things such as farming equipment and two-wheelers. It also helps rural women entrepreneurs get quicker access to funds for their businesses through micro loans.

L&T Financial found G Suite to be a far better collaborative tool to help staff work together efficiently. Employees can interact with each other in real time using Hangouts Meet, and the task of information sharing is more seamless and secure through Drive. BigQuery also helps L&T Financial Services generate behavior scorecards to track credit quality of its micro-loan customers.

“Cloud is the technology that enables us to achieve scale and reach. Today there are countless data points available about rural consumers which enable us to personalize our products to serve them better. With access to faster compute power, we can also on-board consumers more efficiently. Our rural businesses have clocked a disbursement CAGR of 60% over the past three years.” said Sunil Prabhune, Chief Executive-Rural Finance, and Group Head-Digital, IT and Analytics, L&T Financial Services.

Creating conversational connections for Digitate’s customers

Digitate, a venture of TCS (Tata Consultancy Services), has integrated Dialogflow into its flagship brand ignio, an award-winning artificial intelligence platform for driving IT operations, workload operations and ERP operations for diverse enterprises. This integration is the next step in ignio’s product development journey, and will enable users to chat or talk with ignio to detect issues, triage problems, resolve them and even predict system behavior.

“ignio combines its unique self-healing AIOps capabilities for enterprise IT and business operations with Dialogflow’s AI/ML-based, easy to use, natural and rich conversational capabilities to create an unparalleled, intuitive and feature-rich experience for our customers,” says Akhilesh Tripathi, Head of Digitate.

Indian enterprises going G Suite

The base of Indian enterprises that are making the switch to G Suite to streamline their productivity and collaboration also continues to grow. Sharechat, BookMyShow, Hero MotorCorp, DB Corp and Royal Enfield are now able to move faster within their organizations, using intelligent, cloud-based apps to transform the way they work.

A hybrid and multi-cloud future in India

IDC predicts that by 2023, 55% of India 500 organizations will have a multi-cloud management strategy that includes integrated tools across public and private clouds. (IDC FutureScape: Worldwide Cloud 2019 Predictions  — India Implications (# AP43922319). We look forward to sharing more success stories of Indian enterprises that have taken the next step in their digital transformation journey.

The COVID-19 pandemic continues to push the healthcare and life sciences industry in entirely new ways. In record time, we’ve witnessed public health officials, vaccine developers, equipment manufacturers, and essential workers take life saving actions—regularly putting their own lives at risk—to respond to the exceptional challenges of our time. 

Yet after all the turmoil and uncertainty of the pandemic, record breaking levels of investment continue to come into the market to fuel innovations. 

Vaccine development is now measured in weeks rather than years; providers are leveraging telehealth technologies to improve the physician and patient experience; and individuals have embraced a variety of devices to assume greater ownership and control of their personal health. 

With that in mind, here are five of the many innovations I see driving healthcare and life sciences for at least the next 12 months: 

1. Unleashing the power of healthcare and life sciences data

People have arguably never had as much access and understanding to their personal health data than they can in 2022. They have the ability to understand their genetic makeup, medical history, family history, and activity levels to ensure they are living a healthy lifestyle. Taken together, this longitudinal profile can become the basis for more personalized medicine. Add wearable devices to the mix and patients gain real- or near-real-time updates on their health status. 

Further, global regulatory agencies have continued to mandate the need for providers to maintain a longitudinal health record that provides a holistic view of the patient across all the encounters they have had with a health system. Physician surveys conducted by the The Harris Poll and Google Cloud show that a 360-degree view of the patient, across all provider encounters, leads to faster, more accurate diagnosis, and better outcomes. 

If secure data access and interoperability can begin to include insurers, researchers, public health officials, and others in the field, the powerful network effects benefiting patients will only grow. When combined with those longitudinal phenome profiles, the opportunities for personalized and preventative medicine enter a whole new era.

2. Healthcare and life sciences M&A boom continues

Although the pandemic initially slowed activity on mergers and acquisitions in the early part of 2020, the healthcare and life sciences industry has seen a rapid rebound and acceleration of deals ever since. The success of COVID-19 vaccines, the importance of telehealth, and the focus on molecular modeling and genomic-based drug development have all boosted investment as organizations look to enter new markets, develop new therapies, and leverage low interest rates while they last. 

In 2021, the total funding of US digital health startups surpassed $29 billion across 729 deals, according to advisory Rock Health. That’s almost double the levels of 2020, which itself set records. Analysts at PWC meanwhile estimate M&A investments in biopharmaceutical and life sciences could approach $400 billion this year across all sub-sectors

Clearly, the pandemic has been a primary driver of investment as the focus on healthcare has dramatically increased. Yet the increased activity also reflects changing business models and emerging technologies that are now required to compete in the rapidly evolving space. For organizations to capitalize on these investments, it will take not only great vision and intellectual property but also the right technologies—like cloud—and the right data interoperability models, to make partnerships and acquisitions more scalable, feasible, and seamless.

3. Transforming the patient experience at a new rate

The pandemic has shined a spotlight on the inefficiencies and complexities that exist in healthcare markets across the globe. As wave after wave has surged, global healthcare systems remain overwhelmed on most every aspect of patients’ treatment journeys. Even before COVID-19, healthcare was already one of the largest spend areas for governments around the world. The pandemic has only exacerbated the known issues. 

Clearly, administrators, regulators, physicians, nurses, and patients would agree that the processes and models need to change. There’s a need to maintain this momentum and even increase the tempo to achieve lasting change.

Take telehealth. Within months of the start of the pandemic, providers moved to provide more remote capabilities so physicians could still meet with patients virtually to ensure health and safety on all sides. Payers recognized the importance of telehealth and began to update reimbursement rules. And organizations are now reimagining policies in areas such as prior authorization, submission, and adjudication to reduce complexity and bureaucracy while improving responsiveness.

Looking beyond the system, organizations are also recognizing and deepening their understanding of the structural and social determinants of health that impact patient care and health outcomes, especially for historically underserved communities.  Private and public sectors are learning from, and increasingly partnering with, the social sciences, public health, biomedical informatics, computer science, public policy and community groups around how to build a mI’ore equitable and inclusive consumer products and Health IT strategies. 

The newfound levels of transparency, visibility, and accountability that patients, caregivers, and organizations are achieving will ultimately increase competition and provide a more effective, equitable, efficient and, above all, healthier marketplace for all patients. As we move past the worst of the pandemic, regulators and organizations should keep fighting for progress over business as usual.

4. AI is now a core competency for Drug Development

The ability of organizations like Pfizer, Moderna, Johnson & Johnson, and Astrazeneca to develop COVID-19 vaccines has been a remarkable accomplishment—particularly the historic speed with which they were created and deployed. This innovation acceleration was largely enabled by the use of new drug development platforms that allow researchers to use artificial intelligence and machine learning to model protein and cellular interactions to rapidly advance the science.

No longer must researchers rely on traditional laboratory testing (and retesting). With their improved understanding of the molecular and genetic structure of a patient and, for example, their tumor, researchers can use AI to enable simulations on computers rather than testing in live conditions. This technology can process thousands, even millions of simulations to help  identify high-potential candidates for treatment consideration and subsequent analysis. 

AI-enabled drug discovery models can eliminate months and years from the research process, which can reduce the time to develop a drug and accelerate the time to treatment for an individual patient. As just one example, consider the work on AlphaFold2 by Google’s DeepMind unit who leverages AI to predict effective protein shapes for new drugs. Healthcare and life sciences organizations already recognize the potential of AI. Now comes the investments to leverage this rapidly evolving technology to support their efforts now and in the future.   

5. Ecosystem partnerships tackle complexity and spur innovation

As the importance and growth of the healthcare and life sciences industry continues, we will see even more new players and partnerships emerging to address old problems in new ways. This trend will touch all aspects of the healthcare value chain and will, increasingly, see three- and four-player partnerships emerge to address the complex challenges of today’s healthcare marketplace.

Technology will continue to play a key role as capabilities and platforms will transform all aspects of the marketplace. Cell phones, wearable devices, and other technologies will provide real-time updates and notifications to patients on everything from glucose levels to payments for healthcare services. Voice recognition software will document physician and patient discussions to reduce the burden of record keeping. Real-world data will be used to simplify and confidentially recruit patients for participation in clinical trials. 

New players will continue to enter the market to improve health outcomes and reduce costs. Major retailers are among the companies extending their pharmacies to provide additional diagnostic and concierge services, saving patients from additional appointments while boosting prevention. Community organizations are emerging to help identify and care for underserved communities whose health outcomes are significantly lower than the average patient. 

For all the exhausting and heart-wrenching challenges of the past two years, the opportunities the pandemic has laid bare cannot be overlooked. We owe it to those who have worked and fought so hard for every life to forge even more new partnerships—and make it easier to do so—so that the next crisis, when it does arise, will never be as bad as the one we’re now conquering. Technology can be the enabler in this effort and help bring us together to continue to conquer the challenges that lie ahead.